NCT02040142 2024-10-24HIPEC for Peritoneal CarcinomatosisAlbert Einstein College of MedicinePhase 2 Completed51 enrolled 12 charts
NCT02963831 2022-12-22A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal MalignanciesLudwig Institute for Cancer ResearchPhase 1/2 Completed67 enrolled 16 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts